GSR, a leading capital markets partner in the crypto industry, has announced a landmark $100 million private placement into MEI Pharma, Inc. (NASDAQ: MEIP), marking a bold step toward positioning Litecoin (LTC) as an institutional-grade treasury asset. As part of the strategic deal, GSR will assume the role of both strategic advisor and digital asset […]
Source link